Patient understanding of liver cirrhosis and improvement using multimedia education by Goldsworthy, Matthew A. et al.
RESEARCH
Patient understanding of liver
cirrhosis and improvement using
multimedia education
Matthew A Goldsworthy,1 Waleed Fateen,1,2 Helene Thygesen,3
Mark A Aldersley,4 Ian A Rowe,1,4 Rebecca L Jones4
ABSTRACT
Objective For patients to engage with the long-
term management of liver cirrhosis, sufficient
understanding of their condition is essential. The
aim of this study was to assess baseline patient
knowledge and to test whether a condition-
specific multimedia screencast could improve
this.
Design Service quality improvement study.
Setting A UK tertiary liver centre. Patients were
recruited during 12 general hepatology
outpatient clinics.
Patients Fifty-two patients with liver cirrhosis
were included. Sixty-two per cent were male;
their median age was 56 years and their median
clinic attendance period was 3 years.
Interventions Participants completed a baseline
questionnaire assessing their knowledge of the
management and complications of cirrhosis.
They then watched a tailored screencast
discussing this condition, which had been
developed by expert hepatologists in
collaboration with patient representatives.
Knowledge was reassessed using a new copy of
the original questionnaire after an interval of at
least one month.
Main outcome measures Patient scores on
knowledge questionnaires at baseline and
follow-up.
Results Fifty-two patients achieved a median
score of 25.0% before viewing the screencast.
Thirty-five patients then completed a follow-up
questionnaire after an interval period. The
median questionnaire score in this group
improved from 25.0% to 66.7%; an increase of
41.7% compared with baseline (p<0.001).
Conclusions Despite regular review at a specialist
clinic, participants had poor baseline knowledge of
liver cirrhosis. Delivering information by screencast
led to a significant improvement. We therefore
present an effective way to empower patients with
accurate, up-to-date and retainable information
that can easily be translated to many other
conditions.
INTRODUCTION
Chronic liver disease mortality is increas-
ing in the UK, and the number of people
living with the condition also continues
to rise.1 Those individuals with cirrhosis
have an appreciable annual risk of devel-
oping hepatocellular carcinoma (HCC),
of liver decompensation—including vari-
ceal haemorrhage—and of liver-related
mortality.2 It is therefore essential that
these patients engage with ongoing man-
agement, especially surveillance for the
early detection of HCC and oesophageal
varices, as these are seen as primary
methods to reduce mortality in this
population.
Such patient engagement is dependent
upon individuals having sufficient under-
standing of their condition and its man-
agement to allow them to actively
participate in care and make decisions.3 4
Presently, however, patient understanding
may be limited.5 Reasons for this include
the restricted time available for counsel-
ling during clinic consultations and the
variable quality of educational resources
such as websites and information leaf-
lets.6 The inherent complexity of liver
cirrhosis and its complications may also
restrict some patients in achieving sound
understanding. In order for patients to
continually engage with long-term man-
agement, however, it is essential that
effort be made to facilitate them develop-
ing this understanding. Indeed, patient
education has recently been identified as
a key unmet need in the supportive care
of patients with chronic liver disease.7
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Despite this, little evidence exists regarding patient
understanding of cirrhosis or the effectiveness of a
range of educational tools routinely used in practice.
One study was identified in which patients’ knowl-
edge of cirrhosis self-management was tested at a
single centre in the USA.8 This found poor baseline
knowledge that significantly improved after patients
were issued with an information booklet.
In this study, we sought to assess the baseline knowl-
edge of a cohort of patients with liver cirrhosis at a
major UK centre. We then sought to test the effective-
ness of an adjunct to traditional counselling: a
condition-specific multimedia screencast. This is a nar-
rated video that presents relevant and evidence-based
information about liver cirrhosis and its management,
supported by on-screen text, diagrams and anima-
tions. The use of alternative formats to written infor-
mation has been shown to rate favourably in terms of
patient satisfaction and may also increase the accessi-
bility of the information to a wider range of patients.3
Clinical outcomes may also benefit from this
approach. For example, using a video to supplement
verbal counselling and written information was shown
to significantly improve attendance for mammography
screening.9 If such an intervention were to be effective
in improving patient understanding of liver cirrhosis,
it could be used in routine practice as an educational
tool. To our knowledge, this is the first time that such
an intervention has been evaluated in patients with
liver disease.
METHODS
We produced a screencast entitled ‘Understanding
Liver Cirrhosis’. This was developed in collaboration
with consultant hepatologists to ensure its accuracy
and relevance. It was also reviewed by patient repre-
sentatives to ensure suitability for a lay audience. The
12-min long video explains the functions of the liver,
the development of cirrhosis as progression through
inflammation and scarring due to exposure to a causa-
tive factor, the complications that may arise from this
and the associated management strategies. Figure 1
shows a screenshot from the video in which a sche-
matic illustration is being used to explain the develop-
ment of oesophageal varices and the need for
endoscopic surveillance. To maximise accessibility,
simple language was used throughout, supported by
subtitles, images and animations. Signposting, repeti-
tion and summarisation techniques were also used to
aid patient understanding. The full screencast is avail-
able to view online (https://goo.gl/bRd2pH).
We designed a questionnaire with which to assess
patient knowledge of the complications and manage-
ment of liver cirrhosis at baseline, and then again after
viewing the screencast. An initial draft was assessed
for face validity by two members of a patient support
group and three patient liaison staff members.
Improvements to clarity and structure were made in
response to feedback. Content validity was established
through consultation with two consultant hepatolo-
gists with expertise in cirrhosis management.
The final version (see online supplementary file 1)
consisted of six single-best-answer questions, one
multiple-choice question and one short-written-answer
question. The single-best-answer questions had a
two-part structure. The first asked whether the partici-
pant knew the reason for a particular complication or
management strategy, to which they could answer yes
or no. If they answered yes, the second part offered
them three reasons to choose from, along with a fourth
‘other’ option that could be written in a box provided.
This structure was intended to best represent partici-
pants’ understanding by discouraging guessing if they
did not know the answer and by providing space for
them to give a different response if they felt that none
of the options given was suitable. The questions
assessed participants’ knowledge of the reasons for
having ultrasound scans, endoscopies and bone
mineral density scans; their knowledge of the causes of
oesophageal varices and hepatic encephalopathy; their
understanding of the reasons for taking laxatives; their
awareness of muscle wasting, coagulopathy and liver
cancer as being complications of cirrhosis (multiple-
choice question) and their knowledge of the functions
of the liver (short-written-answer question).
Patients with liver cirrhosis attending a general
hepatology outpatient clinic who were aged ≥18 years
and on a surveillance programme for HCC were eli-
gible to participate. Those who were not aware they
had liver cirrhosis were excluded. The medical
records of patients scheduled to attend 12 outpatient
clinics between September 2013 and January 2014
were assessed. Eligible patients were approached on
arrival for their appointment. The study was approved
as a service development project by the department in
which the work was conducted. Informed consent
was obtained from all patients.
Participants first completed a baseline questionnaire
to assess their knowledge of the complications and
management of liver cirrhosis. They then watched the
screencast on a consultation room computer screen,
accompanied, if desired, by a relative or supporter.
Viewers were then asked to evaluate the concept and
quality of the screencast. A new copy of the knowl-
edge questionnaire was sent to patients through the
post after an interval of at least one month (range 1–
6 months). They were asked to complete this without
the help of resources or other people and to return it
by post. We attempted to remind patients who failed
to reply by telephone and offered them the chance to
complete the questionnaire online.
Questionnaires were marked by allocating one point
for a correct answer and no points for any other
response, such as an incorrect answer, no answer or
multiple options selected. Statistical analysis was con-
ducted using SPSS (V.22.0, IBM, Chicago, Illinois,
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USA). Due to skewed distributions, medians and IQRs
are reported as summary measures. The Wilcoxon
signed-rank test was used for paired comparisons of
overall questionnaire scores between baseline and
follow-up. The McNemar test was used to compare
the proportions of correct responses to individual
questions between baseline and follow-up. p<0.05
was considered statistically significant.
RESULTS
Fifty-eight patients were identified from medical
records as being eligible for inclusion. Five of these
answered ‘no’ when asked if they had ever been told
they had liver cirrhosis and were therefore excluded.
One patient declined to participate due to being
frightened of knowing more about cirrhosis. The
remaining 52 patients provided informed consent and
were entered into the study. The characteristics of this
cohort are detailed in table 1. The median clinic
attendance period was 3 years (range 1 month to
13 years). More than 80% of participants had under-
gone upper gastrointestinal endoscopy as screening
for oesophageal varices and more than 90% had
undergone abdominal ultrasound scanning as surveil-
lance for HCC. For patients who recently began
attending this clinic, these procedures had not been
performed by the time of inclusion in this study,
although relevant counselling had been provided at
previous appointments.
Baseline knowledge
When asked to identify complications of cirrhosis in a
multiple-choice question, 8 of the 52 participants
(15%) correctly selected liver cancer, impaired coagu-
lation and muscle wasting; a further eight patients did
not select any of these. Only 25% of patients were
aware that there was a risk of internal bleeding due to
oesophageal varices and just 17% understood that
there was a liability to develop hepatic encephalop-
athy due to impaired clearance of toxins. Four
patients (8%) were aware that laxatives were pre-
scribed to help remove such toxins through the bowel.
Regarding surveillance investigations, of the 48
patients reporting that they had previously undergone
an ultrasound scan of the liver, only 5 (10%) correctly
identified cancer screening as the rationale for regular
scanning in liver cirrhosis. Similarly, of the 43 patients
reporting a previous upper gastrointestinal endoscopy,
only 23 (53%) correctly identified screening for
oesophageal varices as the purpose of this investiga-
tion. Also, 30 patients reported a previous bone
mineral density scan, of which 20 (67%) knew that
the purpose of this was to detect bone weakening.
Overall, the median baseline questionnaire score for
the cohort was 25.0% (IQR 16.7–41.7%). Figure 2
presents the median scores in each aetiology sub-
group. Patients with non-alcoholic fatty liver disease
Figure 1 An image from the screencast in which the presenter (WF) draws a schematic illustration to explain the development of
oesophageal varices in liver cirrhosis.
Table 1 Demographic data for patients who completed the
baseline and follow-up questionnaires
Follow-up questionnaire
Baseline (n=52) Yes (n=35) No (n=17)
Gender—n (%)
Male 32 (61.5%) 22 (62.9%) 10 (58.8%)
Female 20 (38.5%) 13 (37.1%) 7 (41.2%)
Age, years—median
(IQR)
55.5 (20.5) 62.0 (15.0) 48.0 (17.0)
Clinic attendance
period, years—
median (IQR)
3.0 (2.0) 3.0 (2.0) 3.0 (2.5)
Diagnosis—n (%)
Alcohol-related
liver disease
19 (36.5%) 12 (34.3%) 7 (41.2%)
Viral hepatitis 10 (19.2%) 8 (22.9%) 2 (11.8%)
Non-alcoholic
fatty liver disease
9 (17.3%) 8 (22.9%) 1 (5.9%)
Cholestatic liver
disease
9 (17.3%) 5 (14.3%) 4 (23.5%)
Other 5 (9.6%) 2 (5.7%) 3 (17.6%)
Reported previous
endoscopy—n (%)
43 (82.7%) 28 (80.0%) 15 (88.2%)
Reported previous
liver ultrasound—n
(%)
48 (92.3%) 31 (88.6%) 17 (100%)
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(n=9) achieved the lowest median score of 16.7%,
while patients in the cholestatic liver disease (n=9)
and ‘other’ (n=5) groups each had the highest median
score of 41.7%.
Follow-up
Follow-up questionnaires were completed by 35
patients (67.3%). The characteristics of this group—
along with those of patients who did not return the
follow-up questionnaire—are detailed in table 1.
At baseline, the median questionnaire score of these
35 participants was 25.0% (IQR 16.7–41.7%). This
increased to 66.7% (IQR 50.0–75.0%) at follow-up,
representing a statistically significant improvement of
41.7% (p<0.001). Evaluating the whole cohort of 52
patients according to the principles of
intention-to-treat analysis (in which no change in
score was assumed for those lost to follow-up), a sig-
nificant overall improvement in median score
remained (33.3%, p<0.001).
Figure 2 Median baseline questionnaire scores grouped by cirrhosis aetiology. NAFLD, non-alcoholic fatty liver disease.
Figure 3 Proportion of responses marked correct for each question on the baseline and follow-up questionnaires (n=35).
DEXA, dual energy X-ray absorptiometry.
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A breakdown of scores at baseline and follow-up
for each question is shown in figure 3. Knowledge of
the reason for having regular ultrasound scans
improved by 25.7% (p=0.004), regular endoscopies
by 42.9% (p<0.001), bone mineral density scans by
60.0% (p<0.001), being prescribed laxatives by
77.1% (p<0.001), risk of variceal bleeding by 51.4%
(p<0.001), liability to develop encephalopathy by
62.9% (p<0.001), knowledge of complications
(muscle wasting, impaired coagulation and liver
cancer) by 12.4% (p=0.067) and knowledge of liver
functions by 28.6% (p=0.001).
Screencast evaluation
The screencast was evaluated by 63 individuals, com-
prising 49 patients and a further 14 relatives or sup-
porters who accompanied them. Of these, 83% rated
the screencast as ‘very useful’; 92% rated the informa-
tion as ‘all relevant’ or ‘mostly relevant’; 84% said
they would be keen to watch this or similar videos on
the internet, and 87% said they were ‘keen’ or ‘very
keen’ to have a good knowledge of their liver condi-
tion, although 16% said that knowing this informa-
tion made them feel scared.
DISCUSSION
The patients participating in this study had previously
been seen in a liver clinic where information about
cirrhosis is regularly delivered by healthcare profes-
sionals and where information leaflets are readily
available. Despite this, baseline understanding was
poor. Indeed, only half the patients who had previ-
ously undergone an endoscopy were able to identify
the reason for this procedure. For liver ultrasound
scanning, the figure was only 10%. This is despite the
requirement for informed consent in advance of these
procedures. Furthermore, almost 10% of the patients
approached in clinic did not recognise that they had
cirrhosis. These findings support the hypothesis that
patients are not sufficiently informed about their
condition.
When education was delivered by screencast, a large
increase in knowledge questionnaire scores was
observed at follow-up, which took place after an inter-
val of at least one month. This suggests that this form
of information delivery enabled sustained retention of
new knowledge. Of course, within the interval period,
patients may have taken the opportunity to seek out
information about their condition from other sources,
which may have contributed to the observed increase
in knowledge scores. From a pragmatic perspective,
this is not overly concerning. Indeed, the experience
of viewing the screencast may have empowered indivi-
duals to take action in order to develop their under-
standing of cirrhosis. There were, however, 17
patients (33%) who did not respond to the follow-up
questionnaire who may not have felt engaged with
this educational process. These individuals were
younger than those who responded to the follow-up
questionnaire and the distribution of cirrhosis aetiolo-
gies was different, with greater proportions having
alcohol-related liver disease and cholestatic liver
disease (table 1). Interestingly, this group actually
achieved a higher median score on the baseline ques-
tionnaire than those who responded to follow-up
(41.7% vs 25.0%). Having a reasonable level of
knowledge to begin with may therefore be one
explanation as to why some patients did not engage
with the latter part of this study.
Regarding the viewer evaluation, strongly positive
feedback was received regarding the format and use-
fulness of the screencast. It was notable however that
16% of participants felt scared by the information.
This illustrates the potential for harm in giving infor-
mation to patients, which should be an important
consideration when implementing new educational
strategies. In the context of this study, patients viewed
the screencast immediately prior to a clinic appoint-
ment, which provided them with an opportunity to
address their concerns with an experienced
professional.
Overall, the results presented here demonstrate that
patient knowledge of cirrhosis was substantially
improved following the use of a simple, low-cost,
multimedia resource. Presenting information in this
form may therefore be a useful way for clinicians to
facilitate partnership working. Patients may also
benefit from the better clinical outcomes associated
with increased engagement: Serper et al10 found that
liver transplant patients with better knowledge of
their medication regimens were more likely to adhere
to treatment and less likely to require readmission to
hospital. A further study by Singal et al11 found that
patients with cirrhosis who felt involved in their care
were more likely to attend for HCC screening.
Further efforts to educate patients as to the purpose
and value of HCC surveillance may help to enhance
this service, which has recently been evaluated as
requiring substantial development in order to improve
outcomes for patients with HCC.12 In light of the
rising prevalence of chronic liver disease, the work
presented here will be extended to generate empirical
evidence as to whether multimedia education
improves factors such as HCC screening attendance,
medication adherence and their associated health out-
comes. This work will involve a larger patient cohort
and evaluate the persistence of improved patient
knowledge over a longer time period.
CONCLUSION
This study demonstrated that patient understanding of
liver cirrhosis is poor. The delivery of relevant infor-
mation by screencast led to a significant improvement
in patients’ knowledge about their condition. We
therefore present an effective way to empower
patients with chronic liver disease with accurate,
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up-to-date and retainable information that could
easily be translated to many other chronic disease con-
ditions and contribute to the improvement of a wide
range of healthcare services.
Significant of this study
What is already known on this topic?
▸ For effective partnership working in clinical practice,
patient knowledge and understanding of their condi-
tion is essential.
▸ There is scarce evidence regarding patient under-
standing of liver cirrhosis and the effectiveness of
current educational strategies.
What this study adds?
▸ The baseline knowledge of a cohort of patients with
liver cirrhosis was poor, despite regular contact with
specialist healthcare providers and surveillance
procedures.
▸ A short educational screencast led to a significant
and sustained improvement in knowledge about the
management and complications of this disease.
How might it impact on clinical practice in the
foreseeable future?
▸ Implementation of education by screencast as an
adjunct to current strategies could improve patient
understanding, and hence their ability to participate
in clinical decision-making and undertake
self-management.
▸ This is a simple approach to patient education that
could be rapidly adopted in other centres and easily
translated to many other conditions.
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